---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-069792"
form_type: "8-K"
ticker: null
cik: "0001567892"
company_name: "Keenova Therapeutics plc"
filed_at: "2026-06-03T11:25:30+00:00"
generated_at: "2026-06-03T11:30:06.051843+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Keenova shareholders elect all 9 director nominees, approve all proposals at annual meeting

## Summary
- All 9 director nominees elected to hold office until 2027 AGM; average ~25.2M votes 'For' per nominee.
- PricewaterhouseCoopers LLP re-appointed as independent auditor with 25.6M 'For' votes.
- Say-on-pay approved (25.0M 'For' vs 0.3M 'Against'); frequency set to 1 year.
- Special resolutions passed: capital reduction (25.3M 'For') and articles of association amendment (25.5M 'For').

## SEC filing metadata
- accession: 0001104659-26-069792
- form_type: 8-K
- cik: 0001567892
- company_name: Keenova Therapeutics plc
- filed_at: 2026-06-03T11:25:30+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/tm2616735d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-069792
- JSON: https://secwatch.observer/filing/0001104659-26-069792.json
- Plain text: https://secwatch.observer/filing/0001104659-26-069792.txt

## Key facts
- Shareholder Votes
  Keenova Therapeutics plc shareholders approved Election of directors to hold office until the 2027 Annual General Meeting at the 2026-06-02 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: FOR AGAINST ABSTAIN BROKER NON-VOTES Paul M. Bisaro 25,282,713 8,884 191,295 310,829
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm
- Shareholder Votes
  Keenova Therapeutics plc shareholders approved Advisory non-binding vote to approve the frequency of future advisory non-binding votes to approve the Company's executive compensation at the 2026-06-02 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: 1 YEAR 2 YEARS 3 YEARS ABSTAIN BROKER NON-VOTES 25,117,919 172,952 726 191,295 310,829
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm
- Shareholder Votes
  Keenova Therapeutics plc shareholders approved Advisory non-binding vote to approve the re-appointment of PricewaterhouseCoopers LLP as independent auditors and to authorize the Audit Committee to set the auditors’ remuneration at the 2026-06-02 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: FOR AGAINST ABSTAIN BROKER NON-VOTES 25,602,426 0 191,295 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm
- Shareholder Votes
  Keenova Therapeutics plc shareholders approved Advisory non-binding vote to approve the Company's executive compensation at the 2026-06-02 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: FOR AGAINST ABSTAIN BROKER NON-VOTES 24,965,301 326,296 191,295 310,829
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm
- Shareholder Votes
  Keenova Therapeutics plc shareholders approved Approve the reduction of Company capital (Special Resolution) at the 2026-06-02 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: FOR AGAINST ABSTAIN BROKER NON-VOTES 25,256,218 35,379 191,295 310,829
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm
- Shareholder Votes
  Keenova Therapeutics plc shareholders approved Approve an amendment to the Company's articles of association (Special Resolution) at the 2026-06-02 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: FOR AGAINST ABSTAIN BROKER NON-VOTES 25,476,547 6,345 0 310,829
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.